STERIS plc — Director's Dealing 2025

Nov 25, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: STERIS plc (STE)
CIK: 0001757898
Period of Report: 2025-11-21

Reporting Person: Madsen Julia (Sr. VP and GM, Life Sciences)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-11-21	Ordinary Shares	M	2872	$114.22	Acquired	13582	Direct
2025-11-21	Ordinary Shares	S	2872	$262	Disposed	10710	Direct
2025-11-21	Ordinary Shares	M	2136	$147.05	Acquired	12846	Direct
2025-11-21	Ordinary Shares	S	2136	$262	Disposed	10710	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-11-21	Employee Stock Option (right to buy)	$114.22	M	2872	Disposed	2028-05-31	Ordinary Shares (2872)	Direct
2025-11-21	Employee Stock Option (right to buy)	$147.05	M	2136	Disposed	2029-05-31	Ordinary Shares (2136)	Direct

Footnotes

F1: As of November 21, 2025, 4,003 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 578 on June 1, 2026, 352 on June 2, 2026; 666 on June 3, 2026; 542 on June 4, 2026; 666 on June 3, 2027; 542 on June 4, 2027 and 666 on June 5, 2028.

F2: This option is fully vested.